More Fun with the Direct/Derivative Distinction

Key Takeaways

• VC Will classifies Jenzabar dilution claims as derivative
• Brookfield precedent remains controlling for equity‑overpayment claims
• Direct claims require a Revlon‑type control‑changing transaction
• Gradual insider share buildup likely stays derivative
• Supreme Court guidance expected on direct‑derivative split

Pulse Analysis

The direct‑versus‑derivative distinction is a cornerstone of Delaware corporate law, dictating who can sue and how recoveries are allocated. Historically, the Brookfield Asset Management decision established that, absent a clear shift in control akin to a Revlon sale, equity overpayment or dilution claims are treated as derivative, meaning any recovery benefits the corporation rather than individual shareholders. This framework aims to prevent fragmented litigation and preserve corporate assets for the collective interest of all stockholders.

Chancellor Will’s recent dismissal of the Gregory M. Raiff Trust case reinforces Brookfield's doctrine. By emphasizing that the insiders’ eleven‑year accumulation of shares did not involve an active bidding process, merger, or sale, the court underscored that gradual share purchases—even when they push ownership from 18% to 91%—do not satisfy the direct‑claim threshold. The ruling also signals that courts will likely continue to require a demonstrable change‑of‑control event, such as a Revlon‑type transaction, before allowing shareholders to bypass the derivative route. Practitioners should therefore advise boards to structure equity issuances and buybacks with an eye toward avoiding inadvertent control shifts that could invite derivative scrutiny.

Looking ahead, the unresolved nuances of the direct‑derivative line are poised for clarification by the Delaware Supreme Court. As boards contemplate shareholder agreements, poison‑pill defenses, and strategic stock repurchases, they must anticipate potential direct‑action challenges if a single shareholder crosses the 50% threshold. A definitive Supreme Court ruling could set concrete parameters for when control‑changing transactions trigger direct claims, influencing corporate governance best practices nationwide and reshaping the risk calculus for both insiders and minority investors.